Scientist-Politicians Seeking To Build Numbers, Influence

Influence Few and far between, scientists serving in and running for Congress say they offer benefits of reasoning, judgment. EYES ON THE PRIZE: Former pharmaceutical executive Charles Sanders hopes to be the Democratic nominee for Senate in North Carolina this fall. Charles Sanders hopes to give Bill Frist some company. Sanders, a cardiologist and former professor of medicine and pharmaceutical executive, is seeking North Carolina's Democratic nomination for the United States Senate. If he w

Written byThomas Durso
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Influence Few and far between, scientists serving in and running for Congress say they offer benefits of reasoning, judgment.

cHARLES sANDERS
EYES ON THE PRIZE: Former pharmaceutical executive Charles Sanders hopes to be the Democratic nominee for Senate in North Carolina this fall.
Charles Sanders hopes to give Bill Frist some company. Sanders, a cardiologist and former professor of medicine and pharmaceutical executive, is seeking North Carolina's Democratic nomination for the United States Senate. If he wins the May 7 primary, Sanders will face the incumbent, Republican stalwart Jesse Helms, this fall.

Sanders says he's running because "I'm just disgusted with what's going on in Washington." He adds: "I've spent a lifetime trying to solve problems and bring people together, and I have unique real-world experience which would serve well in Washington."

If Sanders manages to score a primary win and go on to defeat Helms, he will find few fellow scientists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies